tirzepatide is a glp 1 FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly GLP-1/GIP Tirzepatide Rx | FancyMeds

Toxicon 60 , 52030 (2012)

Mechanisms of control of Mycobacterium tuberculosis by NK cells: Role of glutathione

Nii T, Ishizawa J, Prabhu V, Ruvolo V, Madhukar N, Zhao R, Mu H, Heese L, Kojima K, Garnett MJ, McDermott U, Benes CH, l Charter N, Deacon S, Elemento O, Allen JE, Oster W, Stogniew M, Andreeff M

Further development continued in the HERMIONE Phase II trial, although clinical success was constrained by tumor heterogeneity and variability in HER2 expression

doi: 10.1038/s41598-021-86483-w 108 JosephsK

It was developed by modifying the natural GLP-1 molecule to: Promote albumin binding: This extends circulation time by slowing renal clearance Resist DPP-4 degradation: Structural modifications protect it from the enzyme that breaks down natural GLP-1 Semaglutide selectively binds to and activates the GLP-1 receptor, triggering the same beneficial downstream effects as natural GLP-1but with sustained activity over days rather than minutes